Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2019
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene
Mark A Sellmyer, Sarah A Richman, Katheryn Lohith, et al.
STAR Protocols
|
November 17, 2022
Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation
Gavin I Ellis, Mosha Z Deng, Delaine W Winn, et al.
Cancer Immunology Research
|
November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
Sarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Journal of Addiction Medicine
|
August 14, 2023
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department
Ashish P Thakrar, Sophia Faude, Jeanmarie Perrone, et al.
Frontiers in Oncology
|
September 27, 2021
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
Radhika Thokala, Zev A Binder, Yibo Yin, et al.
Blood
|
July 19, 2011
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
Qian Zhang, Hongyi Wang, Kanchan Kantekure, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 22, 2007
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M Suhoski, Tatiana N Golovina, Nicole A Aqui, et al.
Nano Letters
|
January 27, 2017
Improving T Cell Expansion with a Soft Touch
Lester H Lambert, Geraldine K E Goebrecht, Sarah E De Leo, et al.
Blood
|
April 20, 2018
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy
Theodore W Laetsch, Shannon L Maude, Michael C Milone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2020
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy
Eduardo Huarte, Roddy S O'Connor, Michael T Peel, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2019
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene
Mark A Sellmyer, Sarah A Richman, Katheryn Lohith, et al.
STAR Protocols
|
November 17, 2022
Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation
Gavin I Ellis, Mosha Z Deng, Delaine W Winn, et al.
Cancer Immunology Research
|
November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
Sarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Journal of Addiction Medicine
|
August 14, 2023
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department
Ashish P Thakrar, Sophia Faude, Jeanmarie Perrone, et al.
Frontiers in Oncology
|
September 27, 2021
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
Radhika Thokala, Zev A Binder, Yibo Yin, et al.
Blood
|
July 19, 2011
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
Qian Zhang, Hongyi Wang, Kanchan Kantekure, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 22, 2007
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M Suhoski, Tatiana N Golovina, Nicole A Aqui, et al.
Nano Letters
|
January 27, 2017
Improving T Cell Expansion with a Soft Touch
Lester H Lambert, Geraldine K E Goebrecht, Sarah E De Leo, et al.
Blood
|
April 20, 2018
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy
Theodore W Laetsch, Shannon L Maude, Michael C Milone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2020
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy
Eduardo Huarte, Roddy S O'Connor, Michael T Peel, et al.
Page
of 11